Cited by 980Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsExtracellular vesicles in disease

The DOI matches its Crossref record; 160 of the 162 references it cites were found in a registry or an index.

Targeting drugs to tumours using cell membrane-coated nanoparticles

Fang, Ronnie H., Gao, Weiwei, Zhang, Liangfang·2023·Nature Reviews Clinical Oncology

Open this paper in CoChat — free account

Abstract

Traditional cancer therapeutics, such as chemotherapies, are often limited by their non-specific nature, causing harm to non-malignant tissues. Over the past several decades, nanomedicine researchers have sought to address this challenge by developing nanoscale platforms capable of more precisely delivering drug payloads. Cell membrane-coated nanoparticles (CNPs) are an emerging class of nanocarriers that have demonstrated considerable promise for biomedical applications. Consisting of a synthetic nanoparticulate core camouflaged by a layer of naturally derived cell membranes, CNPs are adept at operating within complex biological environments; depending on the type of cell membrane utilized, the resulting biomimetic nanoformulation is conferred with several properties typically associated with the source cell, including improved biocompatibility, immune evasion and tumour targeting. In comparison with traditional functionalization approaches, cell membrane coating provides a streamlined method for creating multifunctional and multi-antigenic nanoparticles. In this Review, we discuss the history and development of CNPs as well as how these platforms have been used for cancer therapy. The application of CNPs for drug delivery, phototherapy and immunotherapy will be described in detail. Translational efforts are currently under way and further research to address key areas of need will ultimately be required to facilitate the successful clinical adoption of CNPs.

Integrity signals

Registry

Crossref · 10.1038/s41571-022-00699-x

Cites

160 of 160 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Shedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodríguez-Torres, M. D. P., Acosta‐Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 7,038
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Clinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,296
A view on drug resistance in cancer
Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,466
Self-citation
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. P. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Role of CD47 as a Marker of Self on Red Blood Cells
Oldenborg, P., Zheleznyak, A., Fang, Y., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,975
Molecular therapies and precision medicine for hepatocellular carcinoma
Llovet, J. M., Montal, R., Sia, D., & Finn, R. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0073-4 · Cited by 1,965
Extracellular vesicles as a next-generation drug delivery platform
Herrmann, I. K., Wood, M. J. A., & Fuhrmann, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00931-2 · Cited by 1,948
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Self-citation
Nanoparticle biointerfacing by platelet membrane cloaking
Hu, C. J., Fang, R. H., Wang, K.-C., Luk, B. T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C. H., Kroll, A. V., et al. (2015) · Nature · doi:10.1038/nature15373 · Cited by 1,795
Self-citation
Nanoparticles in the clinic: an update
Anselmo, A. C., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10143 · Cited by 1,766
Contribution of platelets to tumour metastasis
Gay, L. J., & Felding‐Habermann, B. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3004 · Cited by 1,708
Cancer-related fatigue—mechanisms, risk factors, and treatments
Bower, J. E. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.127 · Cited by 1,666
Is it time to start transitioning from 2D to 3D cell culture?
Jensen, C., & Teng, Y. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00033 · Cited by 1,640
A guide to vaccinology: from basic principles to new developments
Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,521
Self-citation
Exosome-Mediated Metastasis: Communication from a Distance
Wortzel, I., Dror, S., Kenific, C. M., & Lyden, D. C. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.011 · Cited by 1,294
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,251
Unlocking the potential of antibody–drug conjugates for cancer therapy
Drago, J. Z., Modi, S., & Chandarlapaty, S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00470-8 · Cited by 1,209
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
Lancet, J. E., Uy, G. L., Cortes, J. E., Newell, L. F., Lin, T. L., Ritchie, E. K., Stuart, R. K., Strickland, S. A., Hogge, D. E., Solomon, S. R., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6112 · Cited by 1,031
A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future
Esfahani, K., Roudaia, L., Buhlaiga, N., Rincon, S. V. D., Papneja, N., & Miller, W. H. (2020) · Current Oncology · doi:10.3747/co.27.5223 · Cited by 1,000
Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition
Ren, J., Liu, X., Fang, C., Jiang, S., June, C. H., & Zhao, Y. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1300 · Cited by 942
Cancer Cell Membrane–Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy
Chen, Z., Zhao, P., Luo, Z., Zheng, M., Tian, H., Gong, P., Gao, G., Pan, H., Liu, L., Ma, A.-Q., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b04695 · Cited by 899
Overview of complement activation and regulation
Noris, M., & Remuzzi, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.001 · Cited by 864
Cancer Cell Membrane Camouflaged Cascade Bioreactor for Cancer Targeted Starvation and Photodynamic Therapy
Li, S., Cheng, H. B., Xie, B., Qiu, W., Zeng, J.-Y., Li, C., Wan, S., Zhang, L., Liu, W., & Zhang, X. (2017) · ACS Nano · doi:10.1021/acsnano.7b02533 · Cited by 783
Self-citation
Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization
Dehaini, D., Wei, X., Fang, R. H., Masson, S., Angsantikul, P., Luk, B. T., Zhang, Y., Man, Y. M., Jiang, Y., Kroll, A. V., et al. (2017) · Advanced Materials · doi:10.1002/adma.201606209 · Cited by 775
Self-citation
Graft-versus-host disease
Shlomchik, W. D. (2007) · Nature reviews. Immunology · doi:10.1038/nri2000 · Cited by 736
Vaccines for established cancer: overcoming the challenges posed by immune evasion
van der Burg, S. H., Arens, R., OSSENDORP, F. A., van Hall, T., & Melief, C. J. M. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.16 · Cited by 731
Current approaches in SELEX: An update to aptamer selection technology
Darmostuk, M., Rimpelová, S., Gbelcová, H., & Ruml, T. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.02.008 · Cited by 730
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721
Role of platelets and platelet receptors in cancer metastasis
Schlesinger, M. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0669-2 · Cited by 711
Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination
Yang, R., Xu, J., Xu, L., Sun, X., Chen, Q., Zhao, Y., Peng, R., & Liu, Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b09041 · Cited by 704
Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer
Cao, H., Dan, Z., He, X., Zhang, Z., Yu, H., Yin, Q., & Li, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b03148 · Cited by 697
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Zamarron, B. F., & Chen, W. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.651 · Cited by 681
Biodegradable Biomimic Copper/Manganese Silicate Nanospheres for Chemodynamic/Photodynamic Synergistic Therapy with Simultaneous Glutathione Depletion and Hypoxia Relief
Liu, C., Wang, D., Zhang, S., Cheng, Y., Yang, F., Xing, Y., Xu, T., Dong, H., & Zhang, X. (2019) · ACS Nano · doi:10.1021/acsnano.8b09387 · Cited by 639
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
Gornalusse, G. G., Hirata, R. K., Funk, S. E., Riolobos, L., Lopes, V. S., Manske, G., Prunkard, D., Colunga, A. G., Hanafi, L.-A., Clegg, D. O., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3860 · Cited by 639
Anticancer Platelet‐Mimicking Nanovehicles
Hu, Q., Sun, W., Qian, C., Wang, C., Bomba, H. N., & Gu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201503323 · Cited by 638
Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors
Sun, H., Su, J., Meng, Q., Yin, Q., Chen, L., Gu, W., Zhang, P., Zhang, Z., Yu, H., Wang, S., et al. (2016) · Advanced Materials · doi:10.1002/adma.201602173 · Cited by 637
Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy
Rao, L., Cai, B., Bu, L., Liao, Q.-Q., Guo, S., Zhao, X., Dong, W., & Liu, W. (2017) · ACS Nano · doi:10.1021/acsnano.7b00133 · Cited by 566
Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis
Kang, T., Zhu, Q., Wei, D., Feng, J., Yao, J., Jiang, T., Song, Q., Wei, X., Chen, H., Gao, X., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06477 · Cited by 558
Tangential Flow Filtration for Highly Efficient Concentration of Extracellular Vesicles from Large Volumes of Fluid
Busatto, S., Vilanilam, G. K., Ticer, T. D., Lin, W., Dickson, D. W., Shapiro, S. A., Bergese, P., & Wolfram, J. (2018) · Cells · doi:10.3390/cells7120273 · Cited by 538
Cancer Cell Membrane‐Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging
Rao, L., Bu, L., Cai, B., Xu, J., Li, A., Zhang, W., Sun, Z., Guo, S., Liu, W., Wang, T., et al. (2016) · Advanced Materials · doi:10.1002/adma.201506086 · Cited by 536
Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance
Rao, L., Bu, L., Xu, J., Cai, B., Yu, G., Yu, X., He, Z., Huang, Q., Li, A., Guo, S., et al. (2015) · Small · doi:10.1002/smll.201502388 · Cited by 526
Erythrocyte–Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma
Wang, D., Dong, H., Li, M., Cao, Y., Yang, F., Zhang, K., Dai, W., Wang, C., & Zhang, X. (2018) · ACS Nano · doi:10.1021/acsnano.7b08355 · Cited by 517
Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles
Gao, W., Fang, R. H., Thamphiwatana, S., Luk, B. T., Li, J., Angsantikul, P., Zhang, Q., Hu, C. J., & Zhang, L. (2015) · Nano Letters · doi:10.1021/nl504798g · Cited by 511
Self-citation
nab-Paclitaxel mechanisms of action and delivery
Yardley, D. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.041 · Cited by 510
Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor Immunity
Kroll, A. V., Fang, R. H., Jiang, Y., Zhou, J., Wei, X., Yu, C. L., Gao, J., Luk, B. T., Dehaini, D., Gao, W., et al. (2017) · Advanced Materials · doi:10.1002/adma.201703969 · Cited by 509
Self-citation
Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell Membranes
Zhu, J.-Y., Zheng, D.-W., Zhang, M.-K., Yu, W.-Y., Qiu, W.-X., Hu, J.-J., Feng, J., & Zhang, X.-Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b02786 · Cited by 498
Cell membrane-derived nanomaterials for biomedical applications
Fang, R. H., Jiang, Y., Fang, J. C., & Zhang, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.041 · Cited by 471
Self-citation
Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes
Gao, W., Hu, C. J., Fang, R. H., Luk, B. T., Su, J., & Zhang, L. (2013) · Advanced Materials · doi:10.1002/adma.201300638 · Cited by 467
Self-citation
Biomimetic proteolipid vesicles for targeting inflamed tissues
Molinaro, R., Corbo, C., Martinez, J. O., Taraballi, F., Evangelopoulos, M., Minardi, S., Yazdi, I. K., Zhao, P., Rosa, E. D., Sherman, M. B., et al. (2016) · Nature Materials · doi:10.1038/nmat4644 · Cited by 459
Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy
Zhang, Y. X., Cai, K., Li, C., Guo, Q., Chen, Q., He, X., Liu, L., Zhang, Y., Lü, Y., Chen, X., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.7b05263 · Cited by 448
Erythrocyte Membrane Cloaked Metal–Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy
Zhang, L., Wang, Z., Zhang, Y., Cao, F., Dong, K., Ren, J., & Qu, X. (2018) · ACS Nano · doi:10.1021/acsnano.8b05200 · Cited by 447
Self-citation
Erythrocyte Membrane Is an Alternative Coating to Polyethylene Glycol for Prolonging the Circulation Lifetime of Gold Nanocages for Photothermal Therapy
Piao, J., Wang, L., Gao, F., You, Y., Xiong, Y., & Yang, L. (2014) · ACS Nano · doi:10.1021/nn503779d · Cited by 428
Cell-Membrane Immunotherapy Based on Natural Killer Cell Membrane Coated Nanoparticles for the Effective Inhibition of Primary and Abscopal Tumor Growth
Deng, G., Sun, Z., Li, S., Peng, X., Li, W., Zhou, L., Ma, Y., Gong, P., & Cai, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b05292 · Cited by 420
Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma
Guo, Y., Wang, D., Song, Q., Wu, T., Zhuang, X., Bao, Y., Kong, M., Yan, Q., Tan, S., & Zhang, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b01042 · Cited by 417
Biomimetic Metal–Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy
Min, H., Wang, J., Qi, Y., Zhang, Y., Han, X., Xu, Y., Xu, J., Li, Y., Chen, L., Cheng, K., et al. (2019) · Advanced Materials · doi:10.1002/adma.201808200 · Cited by 393
Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles
Luk, B. T., Hu, C. J., Fang, R. H., Dehaini, D., Carpenter, C. W., Gao, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr06371b · Cited by 377
Self-citation
Cell Membrane Coated Semiconducting Polymer Nanoparticles for Enhanced Multimodal Cancer Phototheranostics
Li, J., Xu, Z. J., Lyu, Y., Jiang, Y., Huang, J., & Pu, K. (2018) · ACS Nano · doi:10.1021/acsnano.8b04066 · Cited by 377
Engineered Cell‐Membrane‐Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity
Jiang, Y., Krishnan, N., Zhou, J., Chekuri, S., Wei, X., Kroll, A. V., Yu, C. L., Duan, Y., Gao, W., Fang, R. H., et al. (2020) · Advanced Materials · doi:10.1002/adma.202001808 · Cited by 376
Self-citation
Bioinspired Diselenide‐Bridged Mesoporous Silica Nanoparticles for Dual‐Responsive Protein Delivery
Shao, D., Li, M., Wang, Z., Zheng, X., Lao, Y., Chang, Z., Zhang, F., Lu, M., Yue, J., Hu, H., et al. (2018) · Advanced Materials · doi:10.1002/adma.201801198 · Cited by 369
Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles
Zhuang, J., Gong, H., Zhou, J., Zhang, Q., Gao, W., Fang, R. H., & Zhang, L. (2020) · Science Advances · doi:10.1126/sciadv.aaz6108 · Cited by 366
Self-citation
Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma
Chai, Z., Ran, D., Lu, L., Zhan, C., Ruan, H., Hu, X., Xie, C., Jiang, K., Li, J., Zhou, J., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b00661 · Cited by 361
Self-citation
Stem Cell Membrane‐Coated Nanogels for Highly Efficient In Vivo Tumor Targeted Drug Delivery
Gao, C., Lin, Z., Jurado‐Sánchez, B., et al. (2016) · Small · doi:10.1002/smll.201600624 · Cited by 360
Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer
Zhang, F., Li, F., Lu, G., Nie, W., Zhang, L., Lv, Y., Bao, W., Gao, X., Wei, W., Pu, K., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b00892 · Cited by 359
Self-citation
Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy
Xie, W., Deng, W., Zan, M., Rao, L., Yu, G., Zhu, D., Wu, W., Chen, B., Ji, L., Chen, L., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b03788 · Cited by 345
Advancement and applications of peptide phage display technology in biomedical science
Wu, C., Liu, I.-J., Lu, R., & Wu, H. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0223-x · Cited by 343
Biomimetic Nanotechnology toward Personalized Vaccines
Zhou, J., Kroll, A. V., Holay, M., Fang, R. H., & Zhang, L. (2019) · Advanced Materials · doi:10.1002/adma.201901255 · Cited by 336
Self-citation
Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles
Li, J., Ai, Y., Wang, L., Bu, P., Sharkey, C. C., Wu, Q., Wun, B., Roy, S., Shen, X., & King, M. R. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.046 · Cited by 326
‘Marker-of-self’ functionalization of nanoscale particles through a top-down cellular membrane coating approach
Hu, C. J., Fang, R. H., Luk, B. T., Chen, K. N. H., Carpenter, C. W., Gao, W., Zhang, K., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr00015j · Cited by 310
Self-citation
Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy
Ye, X., Liang, X., Chen, Q., Miao, Q., Chen, X., Zhang, X., & Mei, L. (2019) · ACS Nano · doi:10.1021/acsnano.8b07371 · Cited by 308
Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection
Zhang, J., Chen, C., Li, A., Jing, W., Sun, P., Huang, X., Liu, Y., Zhang, S., Du, W., Zhang, R., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-020-00843-7 · Cited by 307
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
Bahmani, B., Gong, H., Luk, B. T., Haushalter, K. J., DeTeresa, E., Previti, M., Zhou, J., Gao, W., Bui, J. D., Zhang, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22311-z · Cited by 307
Self-citation
Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles
Fang, R. H., Hu, C. J., Chen, K. N. H., Luk, B. T., Carpenter, C. W., Gao, W., Li, S., Zhang, D., Lu, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr03064d · Cited by 304
Self-citation
Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production
Ito, Y., Nakamura, S., Sugimoto, N., Shigemori, T., Kato, Y., Ohno, M., Sakuma, S., Ito, K., Kumon, H., Hirose, H., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.011 · Cited by 297
Clearance of pathological antibodies using biomimetic nanoparticles
Copp, J. A., Fang, R. H., Luk, B. T., Hu, C. J., Gao, W., Zhang, K., & Zhang, L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412420111 · Cited by 293
Self-citation
Biomimetic Hybrid Nanozymes with Self-Supplied H + and Accelerated O 2 Generation for Enhanced Starvation and Photodynamic Therapy against Hypoxic Tumors
Yang, X., Yang, Y., Gao, F., Wei, J., Qian, C., & Sun, M. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00934 · Cited by 293
PD‐1 Blockade Cellular Vesicles for Cancer Immunotherapy
Zhang, X., Wang, C., Wang, J., Hu, Q., Langworthy, B., Ye, Y., Sun, W., Lin, J., Wang, T., Fine, J. P., et al. (2018) · Advanced Materials · doi:10.1002/adma.201707112 · Cited by 292
Cancer Cell Membrane-Coated Nanoparticles for Cancer Management
Harris, J. C., Scully, M. A., & Day, E. S. (2019) · Cancers · doi:10.3390/cancers11121836 · Cited by 288
Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
Rao, L., Zhao, S., Wen, C., Tian, R., Lin, L., Cai, B., Sun, Y., Kang, F., Yáng, Z., He, L., et al. (2020) · Advanced Materials · doi:10.1002/adma.202004853 · Cited by 287
Cancer-treatment-induced neurotoxicity—focus on newer treatments
Stone, J. B., & DeAngelis, L. M. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.152 · Cited by 284
Reconstructed Stem Cell Nanoghosts: A Natural Tumor Targeting Platform
Furman, N. E. T., Lupu-Haber, Y., Bronshtein, T., Kaneti, L., Letko-Khait, N., Weinstein, E., Baruch, L., & Machluf, M. (2013) · Nano Letters · doi:10.1021/nl401376w · Cited by 272
Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy
Ren, X., Zheng, R., Fang, X., Wang, X., Zhang, X., Yang, W., & Sha, X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.026 · Cited by 259
Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy
Song, Q., Yin, Y., Shang, L., Wu, T., Zhang, D., Kong, M., Zhao, Y., He, Y., Tan, S., Guo, Y., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03186 · Cited by 258
Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors
Luk, B. T., Fang, R. H., Hu, C. J., Copp, J. A., Thamphiwatana, S., Dehaini, D., Gao, W., Zhang, K., Li, S., & Zhang, L. (2016) · Theranostics · doi:10.7150/thno.14471 · Cited by 251
Self-citation
Janus Nanobullets Combine Photodynamic Therapy and Magnetic Hyperthermia to Potentiate Synergetic Anti‐Metastatic Immunotherapy
Wang, Z., Zhang, F., Shao, D., Chang, Z., Wang, L., Hu, H., Zheng, X., Li, X., Chen, F., Tu, Z., et al. (2019) · Advanced Science · doi:10.1002/advs.201901690 · Cited by 249
Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus
Hu, Q., Qian, C., Sun, W., Wang, J., Chen, Z., Bomba, H. N., Xin, H., Shen, Q., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201603463 · Cited by 244
Biomimetic Diselenide‐Bridged Mesoporous Organosilica Nanoparticles as an X‐ray‐Responsive Biodegradable Carrier for Chemo‐Immunotherapy
Shao, D., Zhang, F., Chen, F., Zheng, X., Hu, H., Yang, C., Tu, Z., Wang, Z., Chang, Z., Lu, J., et al. (2020) · Advanced Materials · doi:10.1002/adma.202004385 · Cited by 238
A Hybrid Eukaryotic–Prokaryotic Nanoplatform with Photothermal Modality for Enhanced Antitumor Vaccination
Chen, Q., Huang, G., Wu, W., Wang, J., Hu, J., Mao, J., Chu, P. K.-H., Bai, H., & Tang, G. (2020) · Advanced Materials · doi:10.1002/adma.201908185 · Cited by 237
Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial‐Membrane‐Coated Nanoparticles
Patel, R. B., Ye, M., Carlson, P. M., Jaquish, A. A., Zangl, L. M., Ma, B., Wang, Y., Arthur, I. S., Xie, R., Brown, R. J., et al. (2019) · Advanced Materials · doi:10.1002/adma.201902626 · Cited by 233
Mitigating the toxic effects of anticancer immunotherapy
Gangadhar, T. C., & Vonderheide, R. H. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.245 · Cited by 227
Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents
Bose, R. J., Sukumar, U. K., Zeng, Y., Afjei, R., Robinson, E. R., Lau, K. H., Bermudez, A., Habte, F. G., Pitteri, S. J., Sinclair, R., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02587 · Cited by 226
A Porous Au@Rh Bimetallic Core–Shell Nanostructure as an H 2 O 2 ‐Driven Oxygenerator to Alleviate Tumor Hypoxia for Simultaneous Bimodal Imaging and Enhanced Photodynamic Therapy
Wang, J., Sun, J., Hu, W., Wang, Y., Chou, T., Zhang, B., Zhang, Q., Ren, L., & Wang, H. (2020) · Advanced Materials · doi:10.1002/adma.202001862 · Cited by 223
Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
Eggermont, L. J., Paulis, L. E. M., Tel, J., & Figdor, C. G. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.06.007 · Cited by 218
Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia
Olsson, M., Bruhns, P., Frazier, W. A., Ravetch, J. V., & Oldenborg, P. (2005) · Blood · doi:10.1182/blood-2004-08-2980 · Cited by 216
Erythrocyte Membrane-Cloaked Polymeric Nanoparticles for Controlled Drug Loading and Release
Aryal, S., Hu, C. J., Fang, R. H., Dehaini, D., Carpenter, C. W., Zhang, D., & Zhang, L. (2013) · Nanomedicine · doi:10.2217/nnm.12.153 · Cited by 215
Self-citation
Biomimetic Magnetosomes as Versatile Artificial Antigen-Presenting Cells to Potentiate T-Cell-Based Anticancer Therapy
Zhang, Q., Wei, W., Wang, P., Zuo, L., Li, F., Xu, J., Xi, X., Gao, X., Ma, G., & Xie, H. (2017) · ACS Nano · doi:10.1021/acsnano.7b04955 · Cited by 213
Antitumor Platelet‐Mimicking Magnetic Nanoparticles
Rao, L., Bu, L., Meng, Q., Cai, B., Deng, W., Li, A., Li, K., Guo, S., Zhang, W., Liu, W., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604774 · Cited by 211
Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes
Su, J., Sun, H., Meng, Q., Zhang, P., Yin, Q., & Li, Y. (2017) · Theranostics · doi:10.7150/thno.17259 · Cited by 210
Genetically engineered cell membrane–coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs
Park, J. H., Jiang, Y., Zhou, J., Gong, H., Mohapatra, A., Heo, J., Gao, W., Fang, R. H., & Zhang, L. (2021) · Science Advances · doi:10.1126/sciadv.abf7820 · Cited by 209
Self-citation
T Cell Membrane Mimicking Nanoparticles with Bioorthogonal Targeting and Immune Recognition for Enhanced Photothermal Therapy
Han, Y., Pan, H., Li, W., Chen, Z., Ma, A.-Q., Yin, T., Liang, R., Chen, F.-M., Ma, Y., Jin, Y., et al. (2019) · Advanced Science · doi:10.1002/advs.201900251 · Cited by 205
Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine
Zou, Y., Liu, Y., Yang, Z., Zhang, D., Lu, Y., Zheng, M., Xue, X., Geng, J., Chung, R., & Shi, B. (2018) · Advanced Materials · doi:10.1002/adma.201803717 · Cited by 203
Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy
Fontana, F., Shahbazi, M., Liu, D., Zhang, H., Mäkilä, E. M., Salonen, J., Hirvonen, J. J., & Santos, H. A. (2016) · Advanced Materials · doi:10.1002/adma.201603239 · Cited by 194
Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection
Zhang, Y., Zhang, J., Chen, W., Angsantikul, P., Spiekermann, K., Fang, R. H., Gao, W., & Zhang, L. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.016 · Cited by 194
Self-citation
Artificial Super Neutrophils for Inflammation Targeting and HClO Generation against Tumors and Infections
Zhang, C., Zhang, L., Wu, W. H., Gao, F., Li, R., Song, W. L., Zhuang, Z., Liu, C., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201901179 · Cited by 194
Self-citation
Expandable Immunotherapeutic Nanoplatforms Engineered from Cytomembranes of Hybrid Cells Derived from Cancer and Dendritic Cells
Liu, W., Zou, M., Liu, T., Zeng, J., Li, X., Yu, W., Li, C., Ye, J., Song, W. L., Feng, J. X., et al. (2019) · Advanced Materials · doi:10.1002/adma.201900499 · Cited by 194
In situ vaccination: Cancer immunotherapy both personalized and off‐the‐shelf
Hammerich, L., Binder, A. F., & Brody, J. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.016 · Cited by 188
Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium.
Glinsky, V. V., Glinsky, G. V., Glinskii, O. V., Huxley, V. H., Turk, J. R., Mossine, V. V., Deutscher, S. L., Pienta, K. J., & Quinn, T. P. (2003) · PubMed · Cited by 186
Nanoparticles disguised as red blood cells to evade the immune system
Fang, R. H., Hu, C. J., & Zhang, L. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.661710 · Cited by 175
Self-citation
Combination immunotherapy approaches
Drake, C. G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds262 · Cited by 171
T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy
Zhai, Y., Wang, J., Lang, T., Kong, Y., Rong, R., Cai, Y., Ran, W., Xiong, F., Zheng, C., Wang, Y., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00972-7 · Cited by 170
Cell Membrane-Camouflaged Nanocarriers with Biomimetic Deformability of Erythrocytes for Ultralong Circulation and Enhanced Cancer Therapy
Miao, Y., Yang, Y., Guo, L., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c00893 · Cited by 163
Targeted Nanomaterials for Phototherapy
Chitgupi, U., Qin, Y., & Lovell, J. F. (2016) · Nanotheranostics · doi:10.7150/ntno.17694 · Cited by 162
Of mice and men: hybridoma and recombinant antibodies
Little, M., Kipriyanov, S. M., Gall, F. L., & Moldenhauer, G. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01668-6 · Cited by 157
Biomimetic Nanoemulsion for Synergistic Photodynamic‐Immunotherapy Against Hypoxic Breast Tumor
Zhang, Y., Liao, Y., Tang, Q., Lin, J., & Huang, P. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202015590 · Cited by 157
Graphene Quantum Dots-Mediated Theranostic Penetrative Delivery of Drug and Photolytics in Deep Tumors by Targeted Biomimetic Nanosponges
Sung, S., Su, Y., Cheng, W., Hu, P.-F., Chiang, C., Chen, W., & Hu, S. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03249 · Cited by 154
Sipuleucel-T
Higano, C. S., Small, E. J., Schellhammer, P. F., Yasothan, U., Gubernick, S. I., Kirkpatrick, P. N., & Kantoff, P. W. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3220 · Cited by 147
Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery
Wang, M., Xin, Y., Cao, H., Li, W., Hua, Y., Webster, T. J., Zhang, C., Tang, W., & Liu, Z. (2020) · Biomaterials Science · doi:10.1039/d0bm01164a · Cited by 144
Transfusion guidelines: when to transfuse
Szczepiorkowski, Z. M., & Dunbar, N. M. (2013) · Hematology · doi:10.1182/asheducation-2013.1.638 · Cited by 138
Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane
Fu, Q., Lv, P., Chen, Z.-K., Ni, D., Zhang, L., Yue, H., Yue, Z., Wei, W., & Ma, G. (2015) · Nanoscale · doi:10.1039/c4nr07027e · Cited by 130
Self-citation
In vivo hitchhiking of immune cells by intracellular self-assembly of bacteria-mimetic nanomedicine for targeted therapy of melanoma
Cheng, G., Wang, Q., Li, J., Kwong, C. H. T., Wei, J., Xie, B., Lu, S., Lee, S. M., & Wang, R. (2022) · Science Advances · doi:10.1126/sciadv.abn1805 · Cited by 130
Virus‐Mimicking Cell Membrane‐Coated Nanoparticles for Cytosolic Delivery of mRNA
Park, J. H., Mohapatra, A., Zhou, J., Holay, M., Krishnan, N., Gao, W., Fang, R. H., & Zhang, L. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202113671 · Cited by 130
Self-citation
Biomimetic Nanoemulsions for Oxygen Delivery In Vivo
Zhuang, J., Man, Y. M., Spiekermann, K., Holay, M., Zhang, Y., Chen, F., Gong, H., Lee, J. H., Gao, W., Fang, R. H., et al. (2018) · Advanced Materials · doi:10.1002/adma.201804693 · Cited by 122
Self-citation
Remote Loading of Small‐Molecule Therapeutics into Cholesterol‐Enriched Cell‐Membrane‐Derived Vesicles
Zhang, X., Angsantikul, P., Man, Y. M., Zhuang, J., Zhang, Q., Wei, X., Jiang, Y., Zhang, Y., Dehaini, D., Chen, M., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707598 · Cited by 116
Self-citation
Bacterial membrane vesicles for vaccine applications
Krishnan, N., Kubiatowicz, L. J., Holay, M., Zhou, J., Fang, R. H., & Zhang, L. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114294 · Cited by 97
Self-citation
Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments
Ganesan, P., Karthivashan, G., Park, S. Y., Kim, J.-S., & Choi, D. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s178077 · Cited by 95
Engineering of stimuli-responsive self-assembled biomimetic nanoparticles
Krishnan, N., Fang, R. H., & Zhang, L. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114006 · Cited by 95
Self-citation
Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy
Xiao, P., Wang, J., Zhao, Z., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.0c04783 · Cited by 91
Traceable Bioinspired Nanoparticle for the Treatment of Metastatic Breast Cancer via NIR‐Trigged Intracellular Delivery of Methylene Blue and Cisplatin
Zhai, Y., Ran, W., Su, J., Lang, T., Meng, J., Wang, G., Zhang, P., & Li, Y. (2018) · Advanced Materials · doi:10.1002/adma.201802378 · Cited by 89
Platelet-Mimicking Biotaxis Targeting Vasculature-Disrupted Tumors for Cascade Amplification of Hypoxia-Sensitive Therapy
Zhang, M., Ye, J.-J., Xia, Y., Wang, Z.-Y., Li, C.-X., Wang, X.-S., Yu, W., Song, W., Feng, J., & Zhang, X.-Z. (2019) · ACS Nano · doi:10.1021/acsnano.9b07330 · Cited by 89
In vitro clinical‐grade generation of red blood cells from human umbilical cord blood CD34+ cells
Baek, E. J., Kim, H., Kim, S., Jin, H., Choi, T. Y., & Kim, H. O. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.01828.x · Cited by 88
Remote‐Loaded Platelet Vesicles for Disease‐Targeted Delivery of Therapeutics
Man, Y. M., Zhuang, J., Wei, X., Zhang, X., Zhang, Y., Jiang, Y., Dehaini, D., Chen, M., Gu, S., Gao, W., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801032 · Cited by 88
Self-citation
A splenic-targeted versatile antigen courier: iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine
Zhai, Y., He, X., Li, Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abi6326 · Cited by 80
Artificial Natural Killer Cells for Specific Tumor Inhibition and Renegade Macrophage Re‐Education
Zou, M., Liu, W., Gao, F., Bai, X., Chen, H., Zeng, X., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201904495 · Cited by 76
Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition
Ai, X., Wang, D., Honko, A. N., Duan, Y., Gavrish, I., Fang, R. H., Griffiths, A., Gao, W., & Zhang, L. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c07798 · Cited by 76
Self-citation
Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response
Zariri, A., Beskers, J., van de Waterbeemd, B., et al. (2016) · Infection and Immunity · doi:10.1128/iai.00635-16 · Cited by 74
Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
Zemek, R. M., Chin, W. L., Nowak, A. K., Millward, M., Lake, R., & Lesterhuis, W. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00223 · Cited by 73
Stem cell membrane-camouflaged targeted delivery system in tumor
Zhang, W., & Huang, X. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100377 · Cited by 71
Physical Disruption of Solid Tumors by Immunostimulatory Microrobots Enhances Antitumor Immunity
Zhou, J., Karshalev, E., Mundaca‐Uribe, R., de Ávila, B. E., Krishnan, N., Xiao, C., Ventura, C. J., Gong, H., Zhang, Q., Gao, W., et al. (2021) · Advanced Materials · doi:10.1002/adma.202103505 · Cited by 70
Self-citation
Erythrocyte Membrane-Wrapped pH Sensitive Polymeric Nanoparticles for Non-Small Cell Lung Cancer Therapy
Gao, L., Wang, H., Nan, L., Peng, T., Sun, L., Zhou, J., Xiao, Y., Wang, J., Sun, J., Lu, W., et al. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00428 · Cited by 64
Self-citation
Bacteria-Inspired Nanomedicine
Holay, M., Guo, Z., Pihl, J., Heo, J., Park, J. H., Fang, R. H., & Zhang, L. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01072 · Cited by 64
Self-citation
Biomimetic Glyconanoparticle Vaccine for Cancer Immunotherapy
Reuven, E. M., Ben‐Arye, S. L., Yu, H., Duchi, R., Perota, A., Conchon, S., Abramovitch, S., Soulillou, J., Galli, C., Chen, X., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b07241 · Cited by 55
Fabrication of red blood cell membrane-camouflaged Cu 2−x Se nanoparticles for phototherapy in the second near-infrared window
Liu, Z., Wang, J., Qiu, K., et al. (2019) · Chemical Communications · doi:10.1039/c9cc03148k · Cited by 39
Cell-membrane coated iron oxide nanoparticles for isolation and specific identification of drug leads from complex matrices
Sherwood, J. A., Sowell, J., Beyer, N., Irvin, J., Stephen, C. A., Antone, A. J., Bao, Y., & Ciesla, L. M. (2019) · Nanoscale · doi:10.1039/c9nr01292c · Cited by 37
Engineering biological interactions on the nanoscale
Jiang, Y., Chekuri, S., Fang, R. H., & Zhang, L. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.10.005 · Cited by 29
Self-citation
Suspension cultures of mammalian cells
Moore, G. E., & Ulrich, K. (1965) · Journal of Surgical Research · doi:10.1016/s0022-4804(65)80017-8 · Cited by 24
Organotropic Targeting of Biomimetic Nanoparticles to Treat Lung Disease
Holay, M., Zhou, J., Park, J. H., Landa, I., Ventura, C. J., Gao, W., Fang, R. H., & Zhang, L. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00599 · Cited by 14
Self-citation

Research works printed but not linked: 1

McCarthy, E. F. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop. J. 26, 154–158 (2006).

Sorted by citations

The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 641
Wnt/β-catenin-driven EMT regulation in human cancers
Xue, W., Yang, L., Chen, C., Ashrafizadeh, M., Tian, Y., & Sun, R. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05099-7 · Cited by 321
Advances in nanoparticles in targeted drug delivery–A review
Islam, S., Ahmed, M. M. S., Islam, M. A., et al. (2025) · Results in Surfaces and Interfaces · doi:10.1016/j.rsurfi.2025.100529 · Cited by 250
Advances of medical nanorobots for future cancer treatments
Kong, X., Gao, P., Wang, J., Fang, Y., & Hwang, K. C. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01463-z · Cited by 260
“The high drug loading capacity, controlled drug release, and the ability to integrate diagnostic reagents have further expanded the scope of the application of nanogels [357].”
Background

See all 980

Authors: Fang, R. H., Gao, W., & Zhang, L.
Affiliations: University of California San Diego (US)
Corresponding author: Zhang, Liangfang
ORCID: Fang, Ronnie H.
Gao, Weiwei
Zhang, Liangfang
Venue: Nature Reviews Clinical Oncology
Publisher: Springer Science and Business Media LLC
Published: 2022-10-28
Volume: 20
Issue: 1
Pages: 33-48
ISSN: 1759-4774 (ISSN-L)
1759-4782
DOI: 10.1038/s41571-022-00699-x
OpenAlex: W4307475977
Semantic Scholar: aad18fe7d6405872bceb0dd4451cf81880d894d6
Cited by: 980
References: 162
Citations by year: 2026: 249 · 2025: 320 · 2024: 281 · 2023: 129 · 2022: 1
FWCI: 12.57
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (R01CA200574)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords: cell membrane-coated nanoparticles, anticancer drug delivery, tumor targeting, biomimetic nanocarriers, immune evasion, phototherapy, cancer immunotherapy, nanoparticle biocompatibility
MeSH terms: Cell Membrane, Pharmaceutical Preparations, Humans, Neoplasms, Drug Delivery Systems, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeting drugs to tumours using cell membrane-coated nanoparticles

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks